These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1304330)

  • 1. Disposition of exogenous tritium-labelled GM1lactone in the rat.
    Bellato P; Milan F; Facchinetti E; Toffano G
    Neurochem Int; 1992 Apr; 20(3):359-64. PubMed ID: 1304330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of ganglioside GM1 after intravenous and intramuscular administration to healthy volunteers.
    Rost KL; Brockmöller J; Weber W; Roots I
    Clin Pharmacol Ther; 1991 Aug; 50(2):141-9. PubMed ID: 1868675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1 after intravenous injection in rats.
    Dumontet C; Rebbaa A; Portoukalian J
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1410-6. PubMed ID: 1482356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of tritium labeled GM1 ganglioside injected in mice.
    Orlando P; Cocciante G; Ippolito G; Massari P; Roberti S; Tettamanti G
    Pharmacol Res Commun; 1979 Oct; 11(9):759-73. PubMed ID: 531082
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental transfer of (3H)-GM1 and its distribution to maternal and fetal tissues of the rat.
    Hungund BL; Morishima HO; Gokhale VS; Cooper TB
    Life Sci; 1993; 53(2):113-9. PubMed ID: 8515685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain content of glycosphingolipids after oral administration of monosialogangliosides GM1 and LIGA20 to rats.
    Polo A; Kirschner G; Guidotti A; Costa E
    Mol Chem Neuropathol; 1994 Jan; 21(1):41-53. PubMed ID: 7910019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of GM1 ganglioside following parenteral administration.
    Cornelli U; Panucci A; Zingali G; Kirschner G; Baggio C; Cogo R
    J Pharm Pharmacol; 1990 Oct; 42(10):708-11. PubMed ID: 1982143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral administration of GM1 ganglioside to presenile Alzheimer patients.
    Svennerholm L; Gottfries CG; Blennow K; Fredman P; Karlsson I; Månsson JE; Toffano G; Wallin A
    Acta Neurol Scand; 1990 Jan; 81(1):48-53. PubMed ID: 2330815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat cerebellar granule cells in culture associate and metabolize differently exogenous GM1 ganglioside molecular species containing a C18 or C20 long chain base.
    Valsecchi M; Chigorno V; Sonnino S; Tettamanti G
    Chem Phys Lipids; 1992; 60(3):247-52. PubMed ID: 1505063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on the incorporation of a tritiated ganglioside, GM1, in the injured and intact sciatic nerves of the rat.
    Lang W; Stotzem CD
    J Neurochem; 1989 Sep; 53(3):929-34. PubMed ID: 2760626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of exogenous gangliosides GM1 and chemically modified GM1 in mice.
    Ogura K; Handa S
    J Biochem; 1988 Jul; 104(1):87-92. PubMed ID: 3220834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Alexa Fluor 350-conjugated nonradioactive or 3H-labeled GM1 ganglioside derivatives with different ceramides.
    Panasiewicz M; Domek H; Fedoryszak N; Pacuszka T
    Anal Biochem; 2009 Feb; 385(1):168-70. PubMed ID: 18983810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss and recovery of activities of alpha+ and alpha isozymes of (Na(+) + K+)-ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function.
    Mahadik SP; Bharucha VA; Stadlin A; Ortiz A; Karpiak SE
    J Neurosci Res; 1992 Jun; 32(2):209-20. PubMed ID: 1328661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
    Simon RP; Chen J; Graham SH
    J Pharmacol Exp Ther; 1993 Apr; 265(1):24-9. PubMed ID: 8474009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the different supramolecular organization on the uptake and metabolization of exogenous GM1 ganglioside by human fibroblasts.
    Giglioni A; Chigorno V; Pitto M; Valsecchi M; Palestini P; Ghidoni R
    Chem Phys Lipids; 1990 Aug; 55(2):207-13. PubMed ID: 2090360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain.
    Duchemin AM; Ren Q; Mo L; Neff NH; Hadjiconstantinou M
    J Neurochem; 2002 May; 81(4):696-707. PubMed ID: 12065629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex.
    Phillis JW; O'Regan MH
    Neuroreport; 1995 Oct; 6(15):2010-2. PubMed ID: 8580429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
    Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
    ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated ganglioside GM1: a potential tool for the investigation of ganglioside function in vivo.
    Zalutsky M; Magistretti P; Gallagher P; Ghidoni R
    Pharmacol Res Commun; 1985 Oct; 17(10):897-912. PubMed ID: 4070340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytes in cell culture incorporate GM1 ganglioside.
    Masco D; Flott B; Seifert W
    Glia; 1989; 2(4):231-40. PubMed ID: 2548962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.